Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo

Infection and Immunity

Volumn 71, Issue 7, 2003, Pages 3857-3865

  Fontaine, Michael C ^a,b   Lee, Jeong Jin ^a,c   Kehoe, Michael A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^c LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOLYSIN O; STREPTOLYSIN S; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE DELETION; GENE SAGB; GENE SLO; LD 50; MOUSE; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; BACTERIAL PROTEINS; BLOOD BACTERICIDAL ACTIVITY; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NECROSIS; SEROTYPING; SKIN; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE; WEIGHT LOSS;

EID: 0037635056     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.7.3857-3865.2003     Document Type: Article

References (62)

1. Alouf, J. 1980. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol. Ther. 11:661-717.
2. Alouf, J., and C. Geoffroy. 1991. The family of antigenically-related cholesterol-binding ('sulphydryl-activated') cytolytic toxins, p. 146-186. In J. Alouf and J. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press Ltd., London, England.
3. Ashbaugh, C., H. Warren, V. Carey, and M. Wessels. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Investig. 102:550-560.
4. Betschel, S., S. Borgia, N. Barg, D. Low, and J. De Azavedo. 1998. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect. Immun. 66:1671-1679.
5. Bisno, A., and D. Stevens. 1996. Streptococcal infections of skin and soft tissues. N. Engl. J. Med. 334:240-245.
6. Biswas, I., A. Gruss, S. D. Ehrlich, and E. Maguin. 1993. High-efficiency gene inactivation and replacement system for gram-positive bacteria. J. Bacteriol. 175:3628-3635.
7. Biswas, I., P. Germon, K. McDade, and J. Scott. 2001. Generation and surface localization of intact M protein in Streptococcuspyogenes are dependent on sagA. Infect. Immun. 69:7029-7038.
8. Bremm, K., W. Konig, P. Pfeiffer, I. Rauschen, K. Theobald, M. Thelestam, and J. Alouf. 1985. Effects of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect. Immun. 50:844-851.
9. Bryant, A., M. A. Kehoe, and D. L. Stevens. 1992. Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes. J. Infect. Dis. 166:165-169.
10. Bunce, C., L. Wheeler, G. Reed, J. Musser, and N. Barg. 1992. Murine model of cutaneous infection with gram-positive cocci. Infect. Immun. 60:2636-2640.
11. Canalias, F., J. Viver, J. Beleta, F. Gonzalez-Sastre, and F. Gella. 1992. Purification and characterization of streptolysin O from Streptococcus pyogenes. Int. J. Biochem. 24:1073-1079.
12. Carr, A., D. Sledjeski, A. Podbielski, M. Boyle, and B. Kreikemeyer. 2001. Similarities between complement-mediated and streptolysin S-mediated haemolysis. J. Biol. Chem. 276:41790-41796.
13. Cheung, A. L., K. J. Eberhardt, and V. A. Fischetti. 1994. A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal. Biochem. 222:511-514.
14. Degnan, B., M. Fontaine, A. Doebereiner, J. Lee, P. Mastroeni, G. Dougan, J. Goodacre, and M. Kehoe. 2000. Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect. Immun. 68:2441-2448.
15. Eberhard, T., D. Sledjeski, and M. D. P. Boyle. 2001. Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, betahemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol. [Online.] http://www.biomedcentral.com /1471-2180/1/33.
16. Ginsberg, I. 1999. Is streptolysin S of group A streptococci a virulence factor? Acta Pathol. Microbiol. Immunol. Scand. 107:1051-1059.
17. Ginsberg, I. 1972. Streptolysin S, p. 99-171. In T. Montie, S. Kadis, and S. Ajl (ed.), Microbial toxins: bacterial protein toxins, vol. 3. Academic Press, Inc., New York, N.Y.
18. Ish-Horowicz, D., and J. F. Burke. 1981. Rapid and efficient cosmid cloning. Nucleic Acids Res. 9:2989-2998.
19. Johnsson, E., K. Berggard, H. Kotarsky, J. Hellwage, P. Zipfel, U. Sjobring, and G. Lindahl. 1998. Role of hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J. Immunol. 161:4894-4901.
20. Kuo, C., J. Wu, K. Lin, P. Tsai, S. Lee, Y. Jin, H. Lei, and Y. Lin. 1998. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect. Immun. 66:3931-3935.
21. Lancefield, R. 1962. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89:307-313.
22. Law, J., G. Buist, A. Haandrikman, J. Kok, G. Venema, and K. Leenhouts. 1995. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J. Bacteriol. 177:7011-7018.
23. Li, Z., D. Sledjeski, B. Kreikemeyer, A. Podbielski, and M. Boyle. 1999. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J. Bacteriol. 181:6019-6027.
24. Limbago, B., V. Penumalli, B. Weinrick and J. Scott. 2000. Role of streptolysin O in a mouse model of invasive group A streptococal disease. Infect. Immun. 68:6384-6390.
25. Liu, S., S. Sela, G. Cohen, J. Jadoun, A. Cheung, and I. Ofek. 1997. Insertional inactivation of streptolysin S expression is associated with altered riboflavin metabolism in Streptococcus pyogenes. Microb. Pathog. 22:227-234.
26. Lukomski, S., E. Burns, P. Wyde, A. Podbielski, J. Rurangirwa, D. Moore-Poveda, and J. Musser. 1998. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect. Immun. 66:771-776.
27. Lukomski, S., C. Montgomery, J. Rurngirwa, R. Geske, J. Barrish, G. Adams, and J. Musser. 1999. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67:1779-1788.
28. Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik A. Podbielski, and J. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of sreotype M3 and M49 strains. J. Clin. Investig. 99:2574-2580.
29. Madden, J., N. Ruiz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of Type III secretion in Gram-positive bacteria. Cell 104:143-152.
30. Maguin, E., P. Duwat, T. Hege, D. Ehrlich, and A. Gruss. 1992. New thermosensitive plasmid for gram-positive bacteria. J. Bacteriol. 174:5633-5638.
31. Maguin, E., H. Prevost, S. Ehrlich, and A. Gruss. 1996. Efficient insertional mutagenesis in lactococci and other gram-positive bacteria. J. Bacteriol. 178:931-935.
32. Malke, H., and J. Ferretti. 1984. Streptokinase: cloning, expression, and excretion by Escherichia coli. Proc. Natl. Acad. Sci. USA 81:3557-3561.
33. Martley, F., A. Jarvis, D. Bacon, and R. Lawrenee. 1970. Typing of coagulasepositive staphylococci by proteolytic activity on buffered caseinate agar with special reference to bacteriophage nontypeable strains. Infect. Immun. 2:439-442.
34. Miles, A., S. Misra, and J. Irwin. 1938. The estimation of the bactericidal power of the blood. J. Hyg. (Cambridge) 38:732.
35. Muller-Alouf, H., C. Greoffroy, P. Geslin, A. Bouvert, A. Felton, E. Gunther, J.-H. Ozegowski, W. Reichardt, and J. Alouf. 1997. Serotype, biotype, pyrogenic exotoxin, streptolysin O, and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bactermia and other severe infections. Adv. Exp. Med. Biol. 418:241-243.
36. Nizet, V., B. Beall, D. J. Bast, V. Datta, L. Kilburn, D. E. Low, and J. C. De Azavedo. 2000. Genetic locus for streptolysin S production by group A streptococcus. Infect. Immun. 68:4245-4254.
37. Ofek, I., S. Bergner-Rabinowitz, and I. Ginsberg. 1972. Oxygen-stable hemolysis of group A streptococci. VIII. Leukotoxic and antiphagocytic effects of streptolysins S and O. Infect. Immun. 6:459-464.
38. Otto, R., W. de Vos, and J. Gravieli. 1982. Plasmid DNA in Streptococcus cremoris Wg2: influence of pH on selection of a variant lacking a protease plasmid. Appl. Environ. Microbiol. 43:1272-1277.
39. Owens, W., F. Henley, and B. Baridge. 1978. Hemolytic mutants of group A Streptococcus pyogenes. J. Clin. Microbiol. 7:153-157.
40. Palmer, M., I. Vulicevic, P. Saweljew, A. Valeva, M. Kehoe, and S. Bhakdi. 1998. Streptolysin O: a proposed model of allosteric interaction between a pore-forming protein and its target lipid bilayer. Biochemistry 37:2378-2383.
41. Perez-Casal, J., M. Caparon, and J. Scott. 1991. Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J. Bacteriol. 173:2617-2624.
42. Pinkney, M., E. Beachey, and M. Kehoe. 1989. The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect. Immun. 57:2553-2558.
43. Pinkney, M., V. Kapur, J. Smith, U. Weller, M. Palmer, M. Glanville, M. Messner, J. Musser, S. Bhakdi, and M. Kehoe. 1995. Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease. Infect. Immun. 63:2776-2779.
44. Prentki, P., and H. Krisch. 1984. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29:303-313.
45. Reed, L., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
46. Ruiz, N., B. Wang, A. Pentland, and M. Caparon. 1998. Streptolysin O and adherence modulate proinflammatory responses of keratinpcytes. Mol. Microbiol. 27:337-346.
47. Sahl, H.-G., and G. Bierbaum. 1998. LANTIBIOTICS: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annu. Rev. Microbiol. 52:41-79.
48. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
49. Schrager, H., J. Rheinwald, and M. Wessels. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Investig. 98:1954-1958.
50. Shanley, T., P. Schrier, V. Kapur, M. Kehoe, J. Musser, and P. Ward. 1996. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect. Immun. 64:870-877.
51. Shiseki, M., K. Miwa, Y. Nemoto, H. Kato, J. Suzuki, K. Sekiya, T. Murai, T. Kikuchi, N. Yamashita, K. Totsuka, K. Ooe, Y. Shimizu, and T. Uchiyama. 1999. Comparison of pathogenic factors expressed by group A streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever. Microb. Pathog. 27:243-252.
52. Siegel, A., E. Johnson, and G. Stollerman. 1961. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. Factors related to the attack rate of rheumatic fever. N. Engl. J. Med. 265:559-566.
53. Simon, D., and A. Chopin. 1988. Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis. Biochimie 70:559-566.
54. Simon, D., and J. Ferretti. 1991. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. Lett. 82:219-224.
55. Stevens, D., and E. Kaplan. 2000. Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, New York, N.Y.
56. Suvorov, A., Y. Tang, C. Yu, and J. Ferretti. 1992. PCR analysis of the streptolysin O (slo) gene of Streptococcus pyogenes, p. 223-224. In G. Orefici (ed.), New perspectives on streptococci and streptococcal diseases. Gustav Fischer Verlag, Stuttgart, Germany.
57. Tewodros, W., M. Norgren, and G. Kronvall. 1995. Streptokinase activity among group A streptococci in relation to streptokinase genotype, plasminogen binding and disease manifestations. Microb. Pathog. 18:53-65.
58. Theodore, T., and G. Calandra. 1981. Streptolysin S activation by lipoteichoic acid. Infect. Immun. 33:326-328.
59. Wannamaker, L. 1983. Streptococcal toxins. Rev. Infect. Dis. 5:S723-S732.
60. Whatmore, A., and M. Kehoe. 1994. Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in vir regulons. Mol. Microbiol. 11:363-374.
61. Wheeler, M., M. Roe, E. Kaplan, P. Schlievert, and J. Todd. 1991. Outbreak of group A Streptococcus septicemia in children. JAMA 266:533-537.
62. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.